• March 2, 2018

    Holland & Knight Helps Bring Reforms To Fla. Prisons

    After more than a year of negotiations with the Florida Department of Corrections, Holland & Knight LLP attorneys, working with Disability Rights Florida and others, recently helped secure a settlement that should help inmates with severe and persistent psychiatric disabilities get the treatment they need.

  • March 2, 2018

    Hawaii Nurse Wins $3.8M Verdict Over Hate Mail, Noose

    A Hawaii jury returned a $3.8 million verdict against Honolulu's The Queen’s Medical Center after a former nurse accused the hospital of ignoring her claims of racial discrimination and harassment, including explicit hate mail and an image of a noose taped to her locker, the nurse’s attorney said Friday.

  • March 2, 2018

    Chiesa Shahinian Loses Atty Fees Challenge Over Standing

    A New Jersey appeals court on Friday denied Chiesa Shahinian & Giantomasi PC's bid to challenge a counsel fees award in a state court action related to a hospital's bills that was initiated by its predecessor, Wolff & Samson PC, amid lingering questions as to whether the successor firm has standing.

  • March 2, 2018

    Tricida Secures $100M In Debt Financing For Latest Drug

    Tricida Inc. has scored $100 million in new financing from life science and technology-focused private equity firm Hercules Capital Inc., the biopharmaceutical company said Friday, as it looks to push forward in the development of its leading drug candidate for chronic kidney disease patients.

  • March 1, 2018

    'Revolving Door' At DEA Faces Scrutiny In Opioid MDL

    The U.S. Drug Enforcement Administration’s resistance to divulging information about opioid sales as part of multidistrict litigation is generating fresh scrutiny of its “revolving door” relationship with drug companies and law firms.

  • March 1, 2018

    3rd Circ. Nixes Part Of 'Hybrid' Medical Device Suit

    The Third Circuit on Thursday upheld in part the dismissal of a suit alleging that a British medical device maker negligently designed a hip replacement system, addressing for the first time whether claims about a device made of components in different classifications are preempted by federal law.

  • March 1, 2018

    Trump May 'Do Some Litigation' Against Opioid Cos.

    President Donald Trump on Thursday discussed the possibility of taking action against pharmaceutical companies that make opioid pain medication, saying he would like to follow the lead of states and “do some litigation,” as part of a policy to combat the epidemic.

  • March 1, 2018

    Pensioners Seek Class OK In Church Plan ERISA Suit

    A group of participants in defined benefit pension plans sponsored by OSF HealthCare System on Wednesday urged an Illinois federal court to certify its class action accusing the Catholic Church-affiliated health care corporation of dodging pension obligations under ERISA.

  • March 1, 2018

    Valeant To Shell Out $58M To End Solodyn Pay-For-Delay MDL

    Valeant Pharmaceuticals International Inc. on Wednesday said it will pay more than $58 million to end pay-for-delay litigation in Massachusetts federal court alleging subsidiary Medicis Pharmaceutical Corp. illegally kept a generic for the acne medication Solodyn off the market.

  • March 1, 2018

    HHS Must Reconsider Formula For ACA Payments

    The U.S. Department of Health and Human Services must reconsider a formula that affects billions of dollars in Affordable Care Act payments to insurers, a New Mexico federal judge said Wednesday.

  • March 1, 2018

    Political Cash 'Taint' Leads To Row Over Class Action Lead

    A group of law firms clashed in D.C. federal court Thursday over whether political contributions by two of the firms should disqualify them from serving as lead counsel in a proposed shareholder class action against Mallinckrodt PLC over the company's alleged attempts to monopolize the market for Acthar, an infant seizure treatment.

  • March 1, 2018

    Jury Says Omnicare Didn’t Misclassify Drivers In FLSA Suit

    A West Virginia federal jury concluded Thursday that pharmacy services provider Omnicare Inc. didn’t violate the Fair Labor Standards Act by intentionally misclassifying a group of drivers as independent contractors to avoid paying them overtime compensation they had earned.

  • March 1, 2018

    Details Emerge On DEA Data Release In Opioid MDL

    The U.S. Drug Enforcement Administration will divulge two years of information about drugmakers that sold the vast majority of opioids in every state, an Ohio federal judge presiding over multidistrict litigation said Thursday.

  • March 1, 2018

    Ex-Lab Execs Fight $17M Medicare Fraud Jury Verdict

    A medical testing laboratory’s former head and two marketing consultants on Wednesday urged a South Carolina federal judge to nix a roughly $17 million jury verdict on civil claims of Medicare fraud, arguing that the decision, which is subject to trebling, was contrary to the evidence and that the trial had been unfair.

  • March 1, 2018

    Mortuary Hit With $15M Judgment In Whistleblower Suit

    An Alabama federal judge hit a mortuary with a $14.7 million judgment in a False Claims Act suit Wednesday, after a jury sided with the whistleblower alleging the mortuary's owner threatened to cremate him alive for exposing a kickback and false billing scheme.

  • March 1, 2018

    PTAB Upholds Eye Treatment Tool Patent

    The Patent Trial and Appeal Board on Wednesday upheld a patent covering a tool used to treat an eye disorder, finding accused infringer MiBo Medical Group hadn’t shown the invention was obvious.

  • March 1, 2018

    Whistleblowers Get $1.3M Cut Of $4.4M Mt. Sinai FCA Deal

    The federal government will pay two whistleblowers $1.3 million for filing a False Claims Act suit against Mount Sinai Hospital that resulted in a $4.4 million settlement with the government, according to a filing in New York federal court Wednesday.

  • March 1, 2018

    Miami-Dade County Hires Legal Team To Launch Opioid Suit

    Miami-Dade County has hired a team of litigators led by Podhurst Orseck PA to prepare legal action against drug manufacturers and distributors for enabling the opioid addiction crisis that has cost the county millions in increased law enforcement and health care costs.

  • March 1, 2018

    Fla. Jury Awards Doctor $2.85M In Whistleblower Trial

    A Florida state jury has awarded a surgeon $2.85 million, finding that he was retaliated against when his former employer, Florida Hospital, fired him for blowing the whistle on practices at the Heart and Lung Transplant Institute that put patients at risk.

  • March 1, 2018

    Navajo Lose Quick Bid To Halt Head Start Funding Cuts

    A D.C. federal judge on Wednesday refused a request from the Navajo Nation to immediately halt a $7.3 million reduction in the government’s funding for the tribe’s early childhood education programs, saying that sagging enrollment numbers and existing funds made a quick change unnecessary.

Expert Analysis

  • What To Expect From FCA Investigations This Year

    Jaimie Nawaday

    The investigation and filing of False Claims Act cases will continue apace in 2018. There are common mistakes to avoid in responding to such investigations, mistakes that I repeatedly witnessed during my tenure in the civil frauds unit of the Southern District of New York, says Jaimie Nawaday of Kelley Drye & Warren LLP.

  • Top 4 Health Care Cybersecurity Threats For 2018

    Brad Sayles

    2017 introduced some of the largest and most widespread cybersecurity attacks in recent memory, and the health care industry was shown to be particularly vulnerable. Brad Sayles of Nelson Mullins Riley & Scarborough LLP discusses the most significant risks health care providers should be on the watch for this year.

  • Employers Must Note Major Tax Law Changes For 2018

    Peter Salomon

    The recently signed tax reform law will affect nearly every aspect of the American economy, and includes several changes to employee benefits and compensation arrangements. Employers must thoroughly review the law's updates to the tax treatment of stock options, compensation of top executives, retirement plan loans, IRA conversions and other activities, say attorneys with Akerman LLP.

  • The Broader Implications Of Sessions’ Marijuana Move

    Markus Funk

    Beyond what it heralds for the marijuana industry, Jeff Sessions’ memo on marijuana enforcement signals a new era of increasingly decentralized federal prosecutorial power, say attorneys with Perkins Coie LLP, including former Colorado Chief Justice Michael Bender.

  • Litigation Finance Trends To Watch In 2018

    Jay Greenberg

    Jay Greenberg and Max Volsky, co-founders of litigation finance platform LexShares Inc., analyze emerging trends based on conversations with their investors and executives in this rapidly evolving sector.

  • 5 Health Care Policy Issues To Follow In 2018

    Pari Mody

    As the 115th Congress enters its second session, it's expected that health care policy will remain at the forefront. Pari Mody and Kristine Blackwood of Arnold & Porter Kaye Scholer LLP discuss the top five health care policy issues to track this year.

  • The Enneagram And The Practice Of Law

    Jennifer Gibbs

    Study of the Enneagram personality typing system can provide attorneys with better insights into themselves, and into those they interact with professionally, including clients, opposing counsel and judges, says Jennifer Gibbs of Zelle LLP.

  • When Gov't Knowledge Of Industry Practice Bars FCA Claims

    Barbara Rowland

    In its recent decision in Spay v. CVS Caremark, the Third Circuit adopted the government knowledge inference defense, thereby offering False Claims Act defendants in the circuit another weapon in their arsenal of defenses to obtain dismissal of FCA claims, say Barbara Rowland and Carolyn Kendall of Post & Schell PC.

  • Massachusetts Marijuana Regulatory Scheme Takes Shape

    Robert Munnelly Jr.

    Massachusetts' emerging regulatory program for both recreational and medical use marijuana, supervised by its new Cannabis Control Commission, will serve as a national model for cannabis industry players and regulators, say Robert Munnelly Jr. and Shawn McCormack of Davis Malm & D'Agostine PC.

  • Series

    Judging A Book: Tymkovich Reviews 'Gorsuch'

    Timothy Tymkovich

    John Greenya’s new book, “Gorsuch: The Judge Who Speaks for Himself,” offers readers something the confirmation hearings did not — the backstory of Neil Gorsuch and a glimpse of who Justice Gorsuch is, says Chief Judge Timothy Tymkovich of the Tenth Circuit.